2630 — Vigonvita Life Sciences Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$13.68bn
- HK$14.42bn
- CNY102.10m
Annual cashflow statement for Vigonvita Life Sciences Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | 6.43 | -218 | -357 |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | 24.1 | 33.4 | 205 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -16.7 | 41.7 | 16.5 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Other Assets | |||
| Change in Payable / Accrued Expenses | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | 30.7 | -109 | -96.7 |
| Capital Expenditures | -159 | -88.1 | -164 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | -1.66 | -0.265 | -70.2 |
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -161 | -88.4 | -234 |
| Financing Cash Flow Items | -11.8 | -22.1 | -250 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 76.5 | 222 | 660 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -53.5 | 25.2 | 327 |